DEVINTEC PHARMA

We are a privately owned pharmaceutical company, based in Switzerland, pioneer in researching and developing innovative substance-based medical devices.

Devintec Pharma was created to drive Novintethical Global Market Access.
Novintethical Pharma SA was founded in 2009.

OUR MISSION

Developing innovative etiological
treatments to restore natural
epithelial permeability.

OUR STRATEGY

Devintec applies Clinical & Regulatory standards that have brought to life +20 projects of innovative evidence-based medical devices.

7
Projects in clinical development
30%
Turnover invested in R&D in 2019

OUR TEAM

  • Business Development & Licensing
  • Partners and Operations Management
  • Scientific and Medical Marketing
  • Scientific and Medical Affairs
  • Quality Assurance & Regulatory Affairs

KNOW HOW

MARKET DEVELOPMENT

  1. Defining patient-relevant added value and outcomes
  2. Matching unmet needs with research
  3. Product category

1

2

RESEARCH

  1. Discovery raw material
  2. Pre-clinical raw material testing

DEVELOPMENT

Technical
  1. Formulation
  2. Test item
Pre-clinical
  1. Safety
  2. MoA
  3. Efficacy
Technical
  1. Industrial batch
  2. Stability
  3. Final specification
Clinical Study
  1. Safety
  2. Efficacy
  3. Final specification

3

4

REGULATORY APPROVAL
Clinical validation

POST MARKET SURVEILLANCE
AND VIGILANCE

3